Synapse formation in the brain can be enhanced by co-administering three specific nutrients
1Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 77 Mass Ave., Cambridge 02139, MA, USA.
European Journal of Pharmacology
|October 17, 2017
Summary
Restoring memory in early Alzheimer's disease (AD) may be possible by increasing brain levels of uridine, omega-3 fatty acids, and choline. These nutrients support the formation of new synapses, crucial for cognitive function.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Early Alzheimer's disease (AD) is linked to synapse deficiency in the hippocampus.
- This deficiency may stem from accelerated synapse turnover or reduced synaptic membrane production.
- Reduced synaptogenesis correlates with decreased numbers of hippocampal dendritic spines in AD.
Purpose of the Study:
- To investigate the potential of specific nutrients to restore synapses and improve memory in early AD.
- To explore the role of uridine, omega-3 fatty acids (DHA/EPA), and choline in synaptogenesis.
Main Methods:
- The study focuses on the biochemical pathways involved in synaptic formation.
- It examines the role of the Kennedy Cycle and nutrient precursors like uridine, DHA, EPA, and choline.
- Investigates the mechanism of uridine's action, including its conversion to uridine triphosphate (UTP) and interaction with P2Y2 receptors.
Main Results:
- Administering uridine, DHA/EPA, and choline can increase the synthesis of new dendritic spines and synapses.
- These nutrients are rate-limiting precursors in the Kennedy Cycle, essential for synaptic membrane phosphatide formation.
- Uridine enhances synaptic protein production and neurite outgrowth, largely mediated by UTP signaling.
Conclusions:
- Supplementing with uridine, omega-3 fatty acids, and choline offers a potential therapeutic strategy for early AD.
- Restoring synapse formation through these nutrients may help reverse memory impairments associated with Alzheimer's disease.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Neurogenesis and Regeneration of Nervous Tissue
1.8K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.8K
Excitatory and Inhibitory Effects of Neurotransmitters
13.5K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
13.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Neurochemical Transmission: Sites of Drug Action
3.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.7K
Neurotransmitters
2.9K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.9K


